Creating a quick quality-of-life questionnaire for people with short bowel syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project aims to develop a shorter, user-friendly quality-of-life questionnaire tailored to adults with short bowel syndrome and compare responses with the validated SBS QoL instrument. Adult patients who speak and read French and do not have known cognitive disorders will complete both instruments at Hôpital Lyon Sud. Investigators will analyze agreement, completion time, and ease of use to determine whether the shorter tool captures the same quality-of-life domains. The goal is to produce a rapid instrument suitable for routine clinical practice.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 or over
* Patient able to read and speak French
* Patient suffering from short bowel syndrome

Exclusion Criteria:

* Known cognitive disorders

Where it's running

• Hôpital Lyon Sud - CHLS
  Pierre-Bénite, France Recruiting

Study contacts

• Principal investigator: Charlotte BERGOIN, Doctor — Service d'hépato-gastro-entérologie et Assistance nutritionnelle - Hôpital Lyon Sud - CHLS
• Study coordinator: Charlotte BERGOIN, Doctor
• Email: charlotte.bergoin@chu-lyon.fr
• Phone: +33 04.78.86.38.69

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Resting energy tests in people with normal digestion vs. intestinal failure

  This study tests resting energy expenditure in adults with and without intestinal failure to help tailor nutrition needs.

  Recruiting Institute of Oncology Ljubljana · Ljubljana · NCT07714499

• FT1 for adults with short bowel syndrome: a safe, quick-study test

  This trial tests FT1 vs placebo in adults with short bowel syndrome to see if FT1 is safe and helps with their condition.

  Recruiting Phase 2 Chongqing Peg-Bio Biopharm Co., Ltd. · Nanjing, Jiangsu · NCT07704047

• Glepaglutide for adults with short bowel syndrome and intestinal failure

  This trial tests whether glepaglutide 10 mg given twice weekly can reduce the need for parenteral support in adults with short bowel syndrome and intestinal failure.

  Recruiting at 32 sites Phase 3 Zealand Pharma · Chicago, Illinois and 32 other locations · NCT07197944

• Crofelemer for adults with short bowel syndrome and intestinal failure without a colon

  This trial will test whether taking crofelemer three times a day helps adults with short bowel syndrome and intestinal failure who lack a colon and need parenteral support.

  Recruiting at 8 sites Phase 2 Napo Therapeutics, S.p.A. · Aachen and 7 other locations · NCT06904872

• Evaluating the Eclipse XL1 System for treating Short Bowel Syndrome

  This study is testing a new device called the Eclipse XL1 System to see if it can help improve intestinal function in adults and children with Short Bowel Syndrome.

  Recruiting at 5 sites Eclipse Regenesis, Inc. · Palo Alto, California and 4 other locations · NCT05535361

• Assessing a new treatment for Short Bowel Syndrome

  This study is testing a new treatment for adults with Short Bowel Syndrome to see if it can help improve their condition compared to a placebo.

  Recruiting at 15 sites Phase 2 Hanmi Pharmaceutical Company Limited · Boston, Massachusetts and 14 other locations · NCT04775706

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.